ANIP - Why ANI Pharmaceuticals Considers Corticotropin Gel Its Blockbuster Drug
Corticotropin Gel Recommercialization Strategy
In December 2015, ANI Pharmaceuticals (ANIP) acquired Cortropin Gel Injection (NDA #008975), 40 units/mL and 80 units/mL and for Cortropin-Zinc Injection (NDA #009854), 40 units/mL from Merck and Co. Inc. (MRK), for $75 million and a percentage of future net sales of the products under the NDAs.
In its corporate presentation related to the Corticotropin drugs, ANI Pharmaceuticals stated that it planned on re-commercializing the previously approved brand name drugs, not a generic version of HP Acthar, as some believe. It is on track to file an